Advanced search
Publication Cover
Natural Product Research
Formerly Natural Product Letters
Volume 32, 2018 - Issue 15
Submit an article Journal homepage
304
Views
5
CrossRef citations to date
0
Altmetric
Review Article

The safety assessment of herbals with a new and ethical approach

Eugenio AielloDepartment of Pharmacy, University of Naples Federico II, Naples, ItalyCorrespondence[email protected]
,
Roberto RussoDepartment of Pharmacy, University of Naples Federico II, Naples, Italy
,
Claudia CristianoDepartment of Pharmacy, University of Naples Federico II, Naples, Italy
&
Antonio CalignanoDepartment of Pharmacy, University of Naples Federico II, Naples, Italy
Pages 1838-1848 | Received 03 Aug 2017, Accepted 03 Nov 2017, Published online: 28 Nov 2017

References

  • Anastas PT, Warner JC. 1998. Green chemistry: theory and practice. Oxford [England]; New York: Oxford University Press. ISBN 9780198502340.
  • Assessment report on Avena sativa L., herba and Avena sativa L., fructus, EMEA/HMPC/202967/2007.
  • Assessment report on Rhodiola rosea L., rhizoma et radix, EMA/HMPC/232100/2011.
  • Assessment report on Viscum album L., herba, EMA/HMPC/246778/2009.
  • Barnes DG, Durson ML. 1988. Reference dose (RfD): description and use in health risk assessment. Regul Toxicol Pharmacol. 8:471–486.10.1016/0273-2300(88)90047-5
  • Belitz H-D, Grosch W, Schieberle P. 2009. Food chemistry. 4th revised and extended ed.; p. 469–470.
  • Bézanger-Beauquesne L, Pinkas M, Torck M, Trotin F. 1980. Aesculus hippocastanum L. Plantes médicinales des régions tempérées. 2è ed. Paris: Maloine; p. 164–165.
  • Bombardelli E, Morazzoni P, Griffini A. 1996. Aesculus hippocastanum L. Fitoterapia. 67:483–511.
  • Brown RP, Gerbarg PL, Ramazanov Z. 2002. Rhodiola rosea: a phytomedicinal overview. 56:40–52.
  • Cramer GM, Ford RA, Hall RL. 1978. Estimation of toxic hazard – a decision tree approach. Food and Cosmetics Toxicology. 16:255–276.
  • Directive 2001/83/EC of the european parliament and of the council of 6 November 2001 on the Community code relating to medicinal products for human use. 2001, November 28. OJ L 311; p. 67.
  • Fournier P. 1948. Marronnier d’Inde – Aesculus hippocastanum L. Le livre des plantes médicinales et vénéneuses de France. Paris: P. Lechevalier Éditeur, T.2; p. 475–479.
  • Frank C. Lu, Kacew S. 2002. Fundamentals, target organs and risk assessment. First published 2002 by Taylor & Francis; p. 81–84.
  • Guidance for Industry. Estimating the Maximum Safe Starting Dose in Initial Clinical Trials for Therapeutics in Adult Healthy Volunteers, (CDER). 2005.
  • Guideline for residual solvents, EMA/CHMP/ICH/82260/2006 (ICH guideline Q3C (R6) on impurities).
  • Guideline on specifications: test procedures and acceptance criteria for herbal substances, herbal preparations and herbal medicinal products/traditional herbal medicinal products, EMA/HMPC/162241/2005 Rev. 2.
  • Guideline on the Limits of Genotoxic on the Impurities, EMEA/CHMP/QWP/251344/2006.
  • Harsha K, Preeti P, Manish KP, Harendra K, Amit CK, Devi DJ. 2012. Foaming glycosides: a review. J Pharm. 2(5):23–28.
  • Kroes R, Renwick AG, Cheeseman M, Kleiner J, Mangelsdorf I, Piersma A, Schilter B, Schlatter J, van Schothorst F, Vos JG, et al. 2004. Structure-based thresholds of toxicological concern (TTC): guidance for application to substances present at low levels in the diet. Food Chem Toxicol. 42:65–83.10.1016/j.fct.2003.08.006
  • Olsnes S, Stirpe F, Sandvig K, Pihl A. 1982. Isolation and characterization of viscumin, a toxic lectin from Viscum album L. (mistletoe). 25;257(22):13263–13270.
  • Oser BL, Hall RL. 1977. Criteria employed by the expert panel of fema for the gras evaluation of flavouring substances. Food Cosmet Toxicol. 15:457–466.10.1016/S0015-6264(77)80014-X
  • Paris M, Moyse H. 1981. Abrégé de matière médicale, Tome 1. Paris: Masson; p. 147–150.
  • Schneider E. 1978. Des plantes pour votre santé. Dammarie-Les-Lys: Éditions SDT; p. 124.
  • Scientific Opinion on the substantiation of a health claim related to oat beta-glucan and lowering blood cholesterol and reduced risk of (coronary) heart disease pursuant to Article 14 of Regulation (EC) No 1924/2006. 2010. EFSA Journal. 8(12):1885.
  • Sirtori CR. 2001. Aescin: pharmacology, pharmacokinetics and therapeutic profile. Pharmacol Res. 44(3):183–193.10.1006/phrs.2001.0847
  • U.S. EPA (U.S. Environmental Protection Agency). 2002a, December. A review of the reference dose and reference concentration processes risk assessment forum. Washington, DC: EPA/630/P-02/002F.
  • U.S. EPA (U.S. Environmental Protection Agency). 2002b. Interim reregistration eligibility decision document – fenamiphos office of pesticide programs. Washington, DC: EPA 738-R-02-004.
  • Updated on revision chapters 3 and 5 of the GMP guide, EMA/INS/GMP/809387/2009.
  • Wichtl M, et al. 2003. Plantes thérapeutiques. 2è ed. Paris: Editions Tec et Doc/EM Inter; p. 294–296.

References accessed but not cited in the manuscript

  • Assessment report on Aesculus hippocastanum L., cortex, EMA/HMPC/354157/2011.
  • Barnes J, Anderson LA, Philipson JD. 2007. Herbal medicines. 3rd ed. Pharmaceutical Press; p. 436–446. Available at the EMA-library.
  • Bézanger-Beauquesne L, Pinkas M, Torck M. 1975. Les plantes dans la thérapeutique moderne. Paris: Maloine; p. 55–58.
  • Doehmer J, Eisenbraun J. 2012. Assessment of extracts from mistletoe (Viscum album) for herb-drug interaction by inhibition and induction of cytochrome P450 activities. Phytother Res. 26(1):11–17. doi:10.1002/ptr.3473.
  • Draft Scientific Opinion on Exploring options for providing preliminary advice about possible human health risks based on the concept of Threshold of Toxicological Concern (TTC) EFSA. 2011. http://www.efsa.europa.eu/en/consultations/call/110712a.htm.
  • Guideline on setting health based exposure limits for use in risk identification in the manufacture of different medicinal products in shared facilities, EMA/CHMP/CVMP/SWP/169430/2012.
  • Hall RL, Oser BL. 1970. Recent progress in the consideration of flavoring ingredients under the Food Additives Amendment. 4. GRAS substances. Food Technol. 24(5):25–34.
  • Hellum BH, Tosse A, Hoybakk K, Thomsen M, Rohloff J, Georg Nilsen O. 2010. Potent in vitro inhibition of CYP3A4 and P-glycoprotein by Rhodiola rosea. Planta Med. 76(4):331–338. Japan 6, APP-2, 1982.10.1055/s-0029-1186153
  • KSRNAM Kiso to Rinsho. Clinical report. Kanda: Yubunsha Co., Ltd., 1–5.
  • Kucinskaite A, Poblocka-Olech L, Krauze-Baranowska M, Sznitowska M, Savickas A, Briedis V. 2007. Evaluation of biologically active compounds in roots and rhizomes of Rhodiola rosea L. cultivated in Lithuania. Medicina (Kaunas). 43(6):487–494.
  • Methods for Measuring the Acute Toxicity of Effluents and Receiving Waters to Freshwater and Marine Organisms. 2002. EPA.
  • Munro IC, Ford RA, Kennepohl E, Sprenger JG. 1996. Correlation of structural class with no-observed-effect levels: a proposal for establishing a threshold of concern. Food Chem Toxicol. 34:829–867.10.1016/S0278-6915(96)00049-X
  • NIIRDN Drugs in Japan (Ethical Drugs). Tokyo: Yakugyo Jiho Co., Ltd.
  • Oser BL, Ford RA. 1977. Recent progress in the consideration of flavoring ingredients under the Food Additives Amendment. 10. GRAS substances. Food Technol. 31(1):65–74.
  • Principles for the safety assessment of food additives and contaminants in food. 1987. WHO.
  • Stein GM. 2000. Toxicology of mistletoe and their components. In: B ssing A, editor. Mistletoe. The genus viscum. Amsterdam: Hardwood Academic Publishers; p. 183–194.
  • Suda-Cho, Chiyoda-ku. 1974. V1-1960. Vol. 8. Tokyo 101, Japan: KS Bldg.; p. 118.
  • Zhu J, Wan X, Zhu Y, Ma X, Zheng Y, Zhang T. 2010. Evaluation of salidroside in vitro and in vivo genotoxicity. Drug Chem Toxicol. 33(2):220–226.10.3109/01480540903373654

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.